JP2022502476A5 - - Google Patents

Info

Publication number
JP2022502476A5
JP2022502476A5 JP2021521024A JP2021521024A JP2022502476A5 JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5 JP 2021521024 A JP2021521024 A JP 2021521024A JP 2021521024 A JP2021521024 A JP 2021521024A JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5
Authority
JP
Japan
Prior art keywords
iii
pharmaceutically acceptable
ring
acceptable salt
viii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021521024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502476A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056455 external-priority patent/WO2020081636A1/en
Publication of JP2022502476A publication Critical patent/JP2022502476A/ja
Publication of JP2022502476A5 publication Critical patent/JP2022502476A5/ja
Pending legal-status Critical Current

Links

JP2021521024A 2018-10-16 2019-10-16 インドールahr阻害剤およびその使用 Pending JP2022502476A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746277P 2018-10-16 2018-10-16
US62/746,277 2018-10-16
PCT/US2019/056455 WO2020081636A1 (en) 2018-10-16 2019-10-16 Indole ahr inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2022502476A JP2022502476A (ja) 2022-01-11
JP2022502476A5 true JP2022502476A5 (https=) 2022-10-25

Family

ID=70284697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521024A Pending JP2022502476A (ja) 2018-10-16 2019-10-16 インドールahr阻害剤およびその使用

Country Status (13)

Country Link
US (1) US20220144839A1 (https=)
EP (1) EP3867253A4 (https=)
JP (1) JP2022502476A (https=)
KR (1) KR20210110566A (https=)
CN (1) CN113272305A (https=)
AU (1) AU2019360204A1 (https=)
BR (1) BR112021007017A2 (https=)
CA (1) CA3115711A1 (https=)
EA (1) EA202190726A1 (https=)
IL (1) IL282252A (https=)
MX (1) MX2021004245A (https=)
SG (1) SG11202103796TA (https=)
WO (1) WO2020081636A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
AU2020394424A1 (en) 2019-11-26 2022-06-16 Ikena Oncology, Inc. Polymorphic carbazole derivatives and uses thereof
CA3167283A1 (en) 2020-01-10 2021-07-15 Ikena Oncology, Inc. Ahr inhibitors and uses thereof
US12570638B2 (en) 2020-05-20 2026-03-10 Sail Biomedicines, Inc. Fused imidazole derivatives as AHR antagonists
KR20230066311A (ko) * 2020-06-10 2023-05-15 델릭스 테라퓨틱스, 인크. 삼환형 사이코플라스토겐 및 이의 용도
CN114369097B (zh) * 2020-10-15 2023-07-14 山东轩竹医药科技有限公司 杂芳环类AhR抑制剂
MX2023004847A (es) * 2020-10-28 2023-07-11 Ikena Oncology Inc Combinación de un inhibidor del receptor de hidrocarburos de arilo (ahr) con un inhibidor de pdx o doxorrubicina.
KR20230124583A (ko) 2020-11-23 2023-08-25 이난타 파마슈티칼스, 인코포레이티드 신규한 스피로피롤리딘 유래 항바이러스제
US12540141B2 (en) 2020-11-23 2026-02-03 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
CN114456178B (zh) * 2021-01-13 2023-06-02 北京华森英诺生物科技有限公司 四氢嘧啶[1,2-b]吲唑-4-胺类衍生物作为AhR抑制剂的用途及制备方法
CN114805361B (zh) * 2021-01-17 2024-02-20 上海凌达生物医药有限公司 一类氨基取代的芳香杂环并吡唑类化合物、制备方法和用途
WO2022235605A1 (en) 2021-05-04 2022-11-10 Enanta Pharmaceuticals, Inc. Novel macrocyclic antiviral agents
US11912714B2 (en) 2021-11-12 2024-02-27 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11919910B2 (en) 2021-11-12 2024-03-05 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11858945B2 (en) 2021-11-12 2024-01-02 Enanta Pharmaceuticals, Inc. Alkyne-containing antiviral agents
WO2023107419A1 (en) 2021-12-08 2023-06-15 Enanta Pharmaceuticals, Inc. Saturated spirocyclics as antiviral agents
WO2023137007A1 (en) * 2022-01-11 2023-07-20 Enanta Pharmaceuticals, Inc. Processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid
WO2023196307A1 (en) 2022-04-05 2023-10-12 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
IL315733A (en) 2022-04-08 2024-11-01 SHY Therapeutics LLC Compounds that Interact with RAS Superfamily Proteins for the Treatment of Cancer, Inflammatory, Basoplastic, and Fibrotic Diseases
CN117624168A (zh) * 2022-08-19 2024-03-01 德明药泰生物技术(深圳)有限公司 稠环杂环类化合物及其制备方法和应用
JPWO2024101336A1 (https=) 2022-11-07 2024-05-16
KR20240169284A (ko) 2023-05-24 2024-12-03 경희대학교 산학협력단 AhR-매개 질환의 예방, 개선 또는 치료용 약학적 조성물
WO2025114771A1 (en) 2023-11-29 2025-06-05 Latvian Institute Of Organic Synthesis A new class of aryl hydrocarbon receptor antagonists and their optimisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721356A (en) * 1989-09-15 1998-02-24 Gensia, Inc. Orally active adenosine kinase inhibitors
JP4895806B2 (ja) * 2003-04-09 2012-03-14 エクセリクシス, インク. Tie−2モジュレータと使用方法
AR047969A1 (es) * 2004-02-25 2006-03-15 Schering Corp Pirazolotriazinas como inhibidores de quinasa
PE20100362A1 (es) * 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
CN108290855A (zh) * 2015-07-01 2018-07-17 西北大学 被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途
US20180072741A1 (en) * 2016-09-09 2018-03-15 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
MX2019012431A (es) * 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP2022502476A5 (https=)
JP2020517734A5 (https=)
JP2020531461A5 (https=)
JP2022516401A5 (https=)
Haiges et al. 5-(Fluorodinitromethyl)-2 H-tetrazole and its tetrazolates–Preparation and Characterization of New High Energy Compounds
JP2020532592A5 (https=)
Fershtat et al. Design of hetarylthiofuroxans by nucleophilic substitution of NO 2 group in nitrofuroxans
NO161179B (no) Lagringsmateriale for lagring av termisk energi og fremgangsmaate til fremstilling av materialet.
Siegl Metal‐chelating 1, 3‐bis (2′‐pyridylimino) isoindolines
WO2024137665A3 (en) Rubber compositions comprising antidegradants
JP2001501939A (ja) 除草剤としての置換2,4―ジアミノ―1,3,5―トリアジン
DK171439B1 (da) Fremgangsmåde til fremstilling af en 2-(5,5-disubstitueret 4-oxo(eller -thiono)-2-imidazolin-2-yl)-nicotinsyre, -3-quinolincarboxylsyre eller -benzoesyre eller et derivat deraf
US9522904B2 (en) Method for producing triazinyl-substituted oxindoles
ES2318272T3 (es) Metodos para hacer 6-((4,5-dihidro-1h-imidazol-2-il)amino-)-7-metil-1h-benzimidazol-4-carbonitrilo y su forma de sal preferida.
US3813439A (en) Process for preparation of triamino-guanidine and its salts
Frankel et al. Derivatives of Dicyanamide1
WO2005003104A2 (en) Crystalline forms of lamotrigine monohydrate and anhydrous lamotrigine and a process for their preparation
US3060179A (en) Polymerization of aromatic nitriles
CS269077B1 (cs) Způsob přípravy 5-azacytosinů
Jalový et al. Contribution to the Synthesis of 4, 10-Dinitro-2, 6, 8, 12-tetraoxa-4, 10-diazatetracyclo [5.5. 0.05, 903, 11] dodecane (TEX)
EP0550621A4 (https=)
Hegab et al. Synthesis of hindered hydrazones and their reaction with thionyl chloride
KAUR DERIVATIZATION OF TRIAZINES AND THEIR EVALUATION AS ANTIFUNGAL AGENTS
Chapyshev Recent progress in the chemistry of polyazidoazines
US3479353A (en) Preparation of 6-amino-2,4-bis(dimethylamino)-s-triazine